U.S. - Canada Cross Border Collaboration

U.S - Canada Cross Border Collaboration In Life Sciences & Technology

The Cascadia region, encompassing parts of the U.S. Pacific Northwest and Western Canada, offers significant opportunities for innovative and high-tech companies to thrive. Robust north-south collaboration is based on a vibrant and active ecosystem, top-tier research, access to capital and shared desire to advance innovation and sustainability.

Join us to hear from the U.S. Ambassador to Canada, David L. Cohen, and a panel of special guests, about the opportunities for Cascadia cross-border collaboration in technology, life sciences, and other leading sectors.

Remarks:

David L. Cohen
U.S. Ambassador to Canada
Bio

Panel Discussion

The Hon. Brenda Bailey David L. Cohen Bridgitte Anderson

The Hon. Brenda Bailey, Minister of Jobs, Economic Development and Innovation, Province of British Columbia
David L. Cohen, U.S. Ambassador to Canada
Moderator: Bridgitte Anderson, President & CEO, Greater Vancouver Board of Trade

Business Panel Discussion

Courtney Billington David Llewellyn Scott Phillips David Seymour Lindsay Williams Wendy Hurlbur

Courtney Billington, Head, Government Affairs North America, Johnson & Johnson
David Llewellyn, Chief Commercial Officer, STEMCELL Technologies
Scott Phillips, Founder & CEO, StarFish Medical
David Seymour, Vice President and General Manager, Microsoft Vancouver
Lindsay Williams, Vice President & Managing Director, Stryker Canada
Moderator: Wendy Hurlburt, President & CEO, Life Sciences BC

Friday, March 15, 2024

11:30 AM

Location:Fairmont Hotel Vancouver - Pacific Ballroom
900 W Georgia St
Vancouver

Schedule:Registration & Lunch: 11:30 a.m. - 12:30 p.m. PT
Program: 12:30 – 2:00 p.m. PT

Submit Your Questions

We want you to be part of the discussion. To participate, go to slido.com and use the password #AMBASSADOR

Sponsor Resources

Johnson & Johnson Innovative Medicine is leading where medicine is going, informed and inspired by patients. Applying rigorous science and compassion, we address some of the most complex diseases of our time and unlock the potential medicines of tomorrow. In our diverse therapeutic areas — Oncology, Immunology, Neuroscience, Cardiovascular, Pulmonary Hypertension and Retina — we work continuously to develop treatments, aspiring to find cures, pioneering the path from lab to life, and championing patients every step of the way.
At Johnson & Johnson MedTech, we unleash healthcare expertise, purposeful technology, and a passion for people to transform the future of medical intervention and empower everyone to live their best life possible. We innovate at the intersection of biology and technology to address the world’s most pressing healthcare challenges. In surgery, orthopaedics, vision, and interventional solutions, we continue to help save lives and create a future where healthcare solutions are smarter, less invasive, and more personalized.

The AmCham Canada – Nanos U.S. Business Confidence Index – comprises a semi-annual survey of leading U.S. companies which has become a must have resource on business sentiment and opinion.